CALIPSO: revolutionizing the management of bioproduction processes in healthcare

CALIPSO: revolutionizing the management of bioproduction processes in healthcare

Paris (France) – September 16th, 2021 – Sanofi, Capgemini, Ypso-Facto, GPC Bio, CEA, CentralSupelec announce the launch of the project CALIPSO !

 

• A structuring R&D project for French medical research, financed and coordinated by a consortium of high-profile industrial and public actors.
• An essential mobilisation to accelerate access to new treatments at an acceptable cost, to ensure France’s competitiveness and its health independence.

For more information, download the pdf below or contact us : contact@ypso-facto.com